Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Antonio Chirianni
Trend of Estimated Glomerular Filtration Rate During Ombistasvir/Paritaprevir/Ritonavir Plus Dasabuvir ± Ribavirin in HIV/HCV Co-Infected Patients
PLoS ONE
Multidisciplinary
Related publications
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for Chronic HCV Infection in US Veterans With Psychiatric Disorders
Journal of Medical Virology
Virology
Infectious Diseases
Real-World Experience With Ombitasvir/Paritaprevir Boosted With Ritonavir and Possibly Combined With Dasabuvir and Ribavirin in HCV Infection
Clinical and Experimental Hepatology
Hepatology
Time to Viral Suppression Is Not Related to Achievement of SVR12 in HCV GT1-infected Patients Treated With Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin
Journal of Viral Hepatitis
Virology
Hepatology
Infectious Diseases
Safety of Ombitasvir/Paritaprevir/Ritonavir+dasabuvir in Chronic Hepatitis C Patients With HCV Genotype 1 Infection
Acta Poloniae Pharmaceutica
Pharmacology
Pharmaceutical Science
Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin for 24 Weeks in Patients With HCV GT4 and Compensated Cirrhosis (AGATE-I Part II)
Health Science Reports
Effect of Co-Medications on Paritaprevir, Ritonavir, Ombitasvir, Dasabuvir and Ribavirin Pharmacokinetics: Analysis of Data From Seven Phase II/III Trials
Antiviral Therapy
Infectious Diseases
Pharmacology
Profile of Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir in the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Plasma Indoxyl Sulfate and Estimated Glomerular Filtration Rate
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Estimated Glomerular Filtration Rate (eGFR) in Healthy Kidney Donors
Journal of Medical Science And clinical Research
